×
About 790 results

ALLMedicine™ Uterine Prolapse Center

Research & Reviews  253 results

GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study
https://clinicaltrials.gov/ct2/show/NCT04829058

Feb 23rd, 2023 - The objective of this retrospective and prospective, single-arm, observational, multicenter, post-market study is to evaluate outcomes in women who underwent surgery for vaginal or uterine prolapse with a GYNEMESH PS Mesh.

Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
https://clinicaltrials.gov/ct2/show/NCT04829175

Feb 22nd, 2023 - The objective of this post market, clinical registry is to evaluate the performance of the products of the TVT family of products or vaginal vault or uterine prolapse repair (with laparotomic or laparoscopic approach including robotic assisted) us...

Triple-compartment strategy for abdominal sacral colpopexy using PVDF mesh: one-year re...
https://doi.org/10.1007/s00192-023-05471-y
International Urogynecology Journal; Zargham M, Dehghani M et. al.

Feb 17th, 2023 - Abdominal Sacral Colpopexy (ASC) is one of the best surgical methods to repair apical or uterine prolapse. We aimed to evaluate the short-term results of a triple-compartment open ASC strategy using polyvinylidene fluoride (PVDF) mesh in the treat...

Cervical cancer after the Manchester procedure: a nationwide cohort study.
https://doi.org/10.1007/s00192-023-05481-w
International Urogynecology Journal; Husby KR, Gradel KO et. al.

Feb 11th, 2023 - The Manchester procedure is a successful operation to treat uterine prolapse. However, the influence on cervical cancer remains unknown. We hypothesized a lower risk of cervical cancer after the Manchester procedure. We included all Danish women u...

Outcomes of Manchester procedure combined with high uterosacral ligament suspension for...
https://doi.org/10.1111/jog.15574
The Journal of Obstetrics and Gynaecology Research; Wang Q, Wu N et. al.

Feb 4th, 2023 - The objective of this study was to evaluate the outcomes of the Manchester procedure (MP) with or without concomitant high uterosacral ligament suspension (HUSLS) for treating uterine prolapse. The primary outcomes were to compare the two methods ...

see more →

Clinicaltrials.gov  28 results

GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study
https://clinicaltrials.gov/ct2/show/NCT04829058

Feb 23rd, 2023 - The objective of this retrospective and prospective, single-arm, observational, multicenter, post-market study is to evaluate outcomes in women who underwent surgery for vaginal or uterine prolapse with a GYNEMESH PS Mesh.

Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
https://clinicaltrials.gov/ct2/show/NCT04829175

Feb 22nd, 2023 - The objective of this post market, clinical registry is to evaluate the performance of the products of the TVT family of products or vaginal vault or uterine prolapse repair (with laparotomic or laparoscopic approach including robotic assisted) us...

Vaginal NOTES Hysterectomy Versus Vaginal Hysterectomy
https://clinicaltrials.gov/ct2/show/NCT04886791

Jan 25th, 2023 - The hysterectomy is one of the most performed gynaecological surgeries worldwide. In the Netherlands about 14.500 hysterectomies are performed yearly. The most common benign indications to perform a hysterectomy are abnormal uterine bleeding, uter...

Evolution of Symptoms After Anterior Sacrospinofixation by Autologous Tissues
https://clinicaltrials.gov/ct2/show/NCT04270188

Jan 5th, 2023 - Prolapse is a pathology that can cause pelvic, urinary or sexual functional disorders and impaired quality of life. Although the use of vaginal mesh is a commonly practiced technique to correct prolapse, in recent years health officials have point...

Long-term Evaluation of the Efficacy and Safety of Splentis for the Treatment of Primary Apical Pelvic Organ Prolapse
https://clinicaltrials.gov/ct2/show/NCT05042453

Dec 29th, 2022 - Women who undergo hysteropexy with Splentis via the vaginal route for primary uterine prolapse will be evaluated regarding efficacy and safety in a long term follow-up of 60 months. The primary endpoint is composed of anatomical, subjective and re...

see more →

News  18 results

Options and outcomes for uterine preservation at the time of prolapse surgery
https://www.mdedge.com/obgyn/article/258538/surgery/options-and-outcomes-uterine-preservation-time-prolapse-surgery
Katherine L. Woodburn, MD, Kate Meriwether, MD

Oct 10th, 2022 - ILLUSTRATION: COPYRIGHT KIMBERLY MARTENS FOR OBG MANAGEMENT CASE Patient desires prolapse repair A 65-year-old postmenopausal patient (G3P3) presents to your office with symptoms of a vaginal bulge for more than 1 year. She has no urinary incontin.

Pelvic Floor Dysfunction Imaging: New Guidelines Provide Recommendations
https://www.medscape.com/viewarticle/959390

Sep 23rd, 2021 - New consensus guidelines from a multispecialty working group of the Pelvic Floor Disorders Consortium (PFDC) clear up inconsistencies in the use of magnetic resonance defecography (MRD), and provide universal recommendations on MRD technique, inte...

Postsurgical pain: Optimizing relief while minimizing use of opioids
https://www.mdedge.com/obgyn/article/157450/gynecology/postsurgical-pain-optimizing-relief-while-minimizing-use-opioids
Mikio Nihira, MD, MPH, Adam C. Steinberg, DO

Jan 31st, 2018 - CASE Managing pain associated with prolapse and SUI surgery A 46-year-old woman (G4P4) described 3 years of worsening symptoms related to recurrent stage-3 palpable uterine prolapse. She had associated symptomatic stress urinary incontinence.

Hysterectomy with Ovarian Conservation Tied to CV Risks
https://www.medpagetoday.com/endocrinology/menopause/70267?comment=true

Jan 3rd, 2018 - Action Points Note that this observational study found that women who had hysterectomy without oophorectomy had a higher rate of cardiometabolic complications in later life than matched controls. The biologic rationale for this observation is uncl...

Don’t shy away from vaginal salpingectomy
https://www.mdedge.com/obgyn/article/134813/surgery/dont-shy-away-vaginal-salpingectomy
M. Alexander Otto

Apr 1st, 2017 - SAN ANTONIO – Surgeons at Houston Methodist Hospital reported a 75% success rate in removing both fallopian tubes during vaginal hysterectomy in a study presented at the annual scientific meeting of the Society of Gynecologic Surgeons. Serous ovar.

see more →

Patient Education  17 results see all →